LFMDLifeMD, Inc.

$200M

Q1 2020 Earnings

Healthcare Medical - Pharmaceuticals

Income Statement

Revenue

$4M+59.5% YoY

Gross Profit

$3M59.1% margin

Operating Income

-$2M-40.4% margin

Net Income

-$2M-55.6% margin

EPS (Diluted)

$-0.22

QoQ Revenue Growth

+9.1%

Cash Flow

Operating Cash Flow

$661,355

Free Cash Flow

$592,955

Stock-Based Comp.

$95,900

Balance Sheet

Total Assets

$2M

Total Liabilities

$6M

Stockholders' Equity

-$3M

Cash & Equivalents

$357,877

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$4M	$3M	+59.5%
Gross Profit	$3M	$2M	+25.9%
Operating Income	-$2M	-$563,369	-208.9%
Net Income	-$2M	-$663,747	-260.8%

Revenue Segments

Product Revenues, Net

$3M69%

Software Revenues, Net

$1M31%

LFMD Q1 2020 Earnings — LifeMD, Inc. Revenue & Financial Results | Market Cap Arena